Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new £115 million biomedical research centre will pave the way for treatments for some of the biggest population health issues around the globe, potentially improving the everyday lives of millions.

Li Ka Shing Centre Opening May 2017

Opened with the support of a £20m gift from the Li Ka Shing Foundation, the centre will bring together researchers from related teams to analyse biomedical data from hundreds of thousands of people worldwide, speeding up both our understanding of diseases and the development of new treatments for conditions including cancer, Alzheimer’s and a number of infectious diseases.

The Li Ka Shing Centre for Health Information and Discovery incorporates two related research institutes at the heart of Oxford University's major biomedical campus in Headington. The two research institutes, the Target Discovery Institute (TDI) and the Big Data Institute (BDI), will lead the development of new types of research activity in the University.

Read more

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.